Relationships between mucinous gastric carcinoma, MUC2 expression and survival

doi:10.3748/wjg.v12.i21.3324

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2955)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

382

HTML

2271

Figures (1-3)

167

Tables (1-2)

135

Sum=2955

Jun 7, 2006 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 7, 2006; 12(21): 3324-3331
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3324

Table 1 MUC expression in 31 gastric carcinomas stratified according to Laurén’s classification, Mulligan’s classification, WHO classification and Goseki’s classification n (%)

Parameter	n	MUC2		MUC5AC		MUC5B		MUC6
Parameter	n	+ IHC¹	+ ISH	+ IHC	+ ISH	+ IHC	+ ISH	+ IHC	+ ISH
Laurén
Intestinal	14	3 (21)	13 (93)	8 (57)	7 (50)	12 (86)	5 (36)	6 (43)	6 (43)
Diffuse	12	1 (8)	6 (50)a	9 (75)	8 (67)	9 (75)	3 (25)	5 (42)	3 (25)
Unclassified	5	3 (60)	4 (80)	3 (60)	1 (20)	3 (60)	1 (20)	1 (20)	2 (40)
Mulligan
Intestinal cell	18	5 (28)	16 (89)	11 (61)	8 (44)	15 (83)	6 (33)	7 (39)	7 (39)
Mucous cell	13	2 (15)	7 (54)	9 (69)	8 (62)	9 (69)	3 (23)	5 (38)	4 (31)
Pylorocardiac	0	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
WHO
Papillary	0	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Tubular	14	3 (21)	13 (93)	8 (57)	7 (50)	12 (86)	5 (36)	6 (43)	6 (43)
Mucinous	3	3 (100)^a	3 (100)	2 (67)	0 (0)	2 (67)	0 (0)	0 (0)	1 (33)
Signet-ring cell	12	1 (8)	6 (50)^a	9 (75)	8 (67)	9 (75)	3 (25)	5 (42)	3 (25)
Undifferentiated	2	0 (0)	1 (50)	1 (50)	1 (50)	1 (50)	1 (50)	1 (50)	1 (50)
Goseki
Group I	11	2 (18)	10 (91)	5 (45)	4 (36)	9 (82)	2 (18)	5 (45)	4 (36)
Group II	5	4 (80)^b	5 (100)	4 (80)	2 (40)	4 (80)	2 (40)	1 (20)	2 (40)
Group III	9	0 (0)	4 (44)	6 (67)	5 (56)	5 (56)	3 (33)	3 (33)	4 (44)
Group IV	6	1 (17)	4 (67)	5 (83)	5 (83)	6 (100)	2 (33)	3 (50)	1 (17)

¹ MUC2 positivity in more than 30% of tumoral cells. IHC: Immu-nohistochemistry; ISH: In situ hybridization.

^aP < 0.05,

^bP = 0.01 vs other groups.

Table 2 MUC expression in each component of gastric carcinoma on the basis of Goseki’s classification n(%)

Goseki,	n	MUC2		MUC5AC		MUC5B		MUC6
Goseki,	n	+ IHC	+ ISH	+ IHC	+ ISH	+ IHC	+ ISH	+ IHC	+ ISH
GroupI	21	14 (67)	17 (81)	12 (57)	8 (38)	12 (57)	7 (33)	6 (29)	6 (29)
GroupII	12	10 (83)	10 (83)	7 (58)	7 (58)	8 (67)	5 (42)	5 (42)	7 (58)
GroupIII	10	2 (20)	1 (10)	4 (40)	3 (30)	4 (40)	1 (10)	1 (10)	1 (10)
GroupIV	13	9 (69)	6 (46)	7 (54)	5 (38)	7 (54)	2 (15)	4 (31)	2 (15)

IHC: Immunohistochemistry; ISH: In situ hybridization.

Citation: Leteurtre E, Zerimech F, Piessen G, Wacrenier A, Leroy X, Copin MC, Mariette C, Aubert JP, Porchet N, Buisine MP. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J Gastroenterol 2006; 12(21): 3324-3331
URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3324.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i21.3324